Effects of Serum Aspartate Aminotransferase Levels in Patients With Autoimmune Hepatitis Influence Disease Course and Outcome

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 12, 2008, Pages 1389-1395

  Al Chalabi, Thawab ^a   Underhill, James A ^a   Portmann, Bernard C ^a   McFarlane, Ian G ^a   Heneghan, Michael A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ADULT; AGED; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HEMATEMESIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK FACTOR; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 57149099961     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.08.018     Document Type: Article

References (21)

1. Johnson P.J., and McFarlane I.G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 18 (1993) 998-1005
2. McFarlane I.G. Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features. Clin Liver Dis 6 (2002) 317-333
3. Kirk A.P., Jain S., Pocock S., et al. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut 21 (1980) 78-83
4. Alvarez F., Berg P.A., Bianchi F.B., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
5. Heneghan M.A., and McFarlane I.G. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 35 (2002) 7-13
6. Czaja A.J., Muratori P., Muratori L., et al. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int 24 (2004) 322-329
7. Batts K.P., and Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19 (1995) 1409-1417
8. Johnson P.J., McFarlane I.G., and Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 333 (1995) 958-963
9. Feld J.J., Dinh H., Arenovich T., et al. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 42 (2005) 53-62
10. Soloway R.D., Summerskill W.H., Baggenstoss A.H., et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 63 (1972) 820-833
11. Czaja A.J., and Freese D.K. Diagnosis and treatment of autoimmune hepatitis. Hepatology 36 (2002) 479-497
12. Czaja A.J., and Carpenter H.A. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatology 39 (2004) 1631-1638
13. Williams A.L., and Hoofnagle J.H. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology 95 (1988) 734-739
14. Vento S., McFarlane B.M., Vento T.G., et al. Serial study of liver-directed autoantibodies and autoreactive T-lymphocytes in acute viral hepatitis B. J Autoimmun 1 (1988) 299-307
15. Wai C.T., Greenson J.K., Fontana R.J., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
16. Lackner C., Struber G., Liegl B., et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 41 (2005) 1376-1382
17. Giannini E., Risso D., Botta F., et al. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 163 (2003) 218-224
18. Roberts S.K., Therneau T.M., and Czaja A.J. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 110 (1996) 848-857
19. Ekstedt M., Franzen L.E., Mathiesen U.L., et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44 (2006) 865-873
20. Li D., and Friedman S.L. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol 14 (1999) 618-633
21. Friedman S.L., and Bansal M.B. Reversal of hepatic fibrosis-fact or fantasy?. Hepatology 43 Suppl 1 (2006) S82-S88